Posted by Anthony Bellafiore on Dec 21st, 2024
On December 16, 2024, KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) announced the appointment of Jeb Ledell as the company’s Chief Operating Officer. With a wealth of experience in the biotechnology industry, Ledell, aged 49,...
More of this article »